Coloplast A/S (OTCMKTS:CLPBY) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) posted its quarterly earnings data on Tuesday. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01), Zacks reports. Coloplast A/S had a net margin of 18.69% and a return on equity of 30.19%.

Coloplast A/S Trading Down 1.9 %

Coloplast A/S stock opened at $11.29 on Tuesday. Coloplast A/S has a 12-month low of $10.63 and a 12-month high of $14.34. The firm’s fifty day moving average is $11.48 and its 200 day moving average is $12.58. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92.

Coloplast A/S Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Monday, December 9th were paid a $0.2435 dividend. The ex-dividend date was Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s payout ratio is currently 93.94%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CLPBY shares. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 11th. Hsbc Global Res upgraded shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a report on Monday, November 18th. Finally, Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.